维力医疗全资子公司产品获批进入特别审查程序

财中社12-02

财中社12月2日电维力医疗（603309）发布关于全资子公司产品进入创新医疗器械特别审查程序的公告。公司全资子公司海南维力医疗科技开发有限公司近日收到海南省药品和医疗器械审评服务中心的通知，同意其创新产品“一次性使用亲水涂层可视鼻胃肠管”进入特别审查程序。该产品的注册分类为2类，适用于经鼻向胃肠道输送营养物质、胃肠减压和冲洗。此次产品进入特别审查程序将使其在注册申报时获得优先办理权益，从而有效缩短...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2488562371?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-02 16:12","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2488562371","market":"sh","top_or_hot":-1,"title":"维力医疗全资子公司产品获批进入特别审查程序","media":"财中社","content":"<div>\n<p>财中社12月2日电维力医疗（603309）发布关于全资子公司产品进入创新医疗器械特别审查程序的公告。公司全资子公司海南维力医疗科技开发有限公司近日收到海南省药品和医疗器械审评服务中心的通知，同意其创新产品“一次性使用亲水涂层可视鼻胃肠管”进入特别审查程序。该产品的注册分类为2类，适用于经鼻向胃肠道输送营养物质、胃肠减压和冲洗。此次产品进入特别审查程序将使其在注册申报时获得优先办理权益，从而有效缩短...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161919a265bd0b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>维力医疗全资子公司产品获批进入特别审查程序</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n维力医疗全资子公司产品获批进入特别审查程序\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-02 16:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161919a265bd0b&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社12月2日电维力医疗（603309）发布关于全资子公司产品进入创新医疗器械特别审查程序的公告。公司全资子公司海南维力医疗科技开发有限公司近日收到海南省药品和医疗器械审评服务中心的通知，同意其创新产品“一次性使用亲水涂层可视鼻胃肠管”进入特别审查程序。该产品的注册分类为2类，适用于经鼻向胃肠道输送营养物质、胃肠减压和冲洗。此次产品进入特别审查程序将使其在注册申报时获得优先办理权益，从而有效缩短...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161919a265bd0b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603309","symbol_name":"维力医疗","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161919a265bd0b&s=b","article_id":"2488562371","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161919a265bd0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2488562371","pubTimestamp":1733127146,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"公司全资子公司海南维力医疗科技开发有限公司近日收到海南省药品和医疗器械审评服务中心的通知，同意其创新产品“一次性使用亲水涂层可视鼻胃肠管”进入特别审查程序。此次产品进入特别审查程序将使其在注册申报时获得优先办理权益，从而有效缩短注册周期，加快上市速度。2024年前三季度，维力医疗实现收入10.60亿元，归母净利润1.67亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603309":"维力医疗","BK0251":"专用设备"},"translate_title":"The products of Weili Medical's wholly-owned subsidiary were approved to enter the special review process","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603309":1},"content_text":"财中社12月2日电维力医疗（603309）发布关于全资子公司产品进入创新医疗器械特别审查程序的公告。公司全资子公司海南维力医疗科技开发有限公司近日收到海南省药品和医疗器械审评服务中心的通知，同意其创新产品“一次性使用亲水涂层可视鼻胃肠管”进入特别审查程序。该产品的注册分类为2类，适用于经鼻向胃肠道输送营养物质、胃肠减压和冲洗。此次产品进入特别审查程序将使其在注册申报时获得优先办理权益，从而有效缩短注册周期，加快上市速度。如该产品获批上市，将进一步丰富公司的产品管线，对公司的业务产生积极影响。目前国内尚无同类产品，海南维力研发的可视鼻肠管具备较高的临床价值和卫生经济学价值。虽然进入审查程序为公司带来了机遇，但产品上市仍存在不确定性，未来经营业绩的具体影响尚无法预测。2024年前三季度，维力医疗实现收入10.60亿元，归母净利润1.67亿元。文章来源：财中社原标题：维力医疗全资子公司产品获批进入特别审查程序","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488562371"}